Lactic acidosis, a potential toxicity from drug–drug interaction related to concomitant ribociclib and metformin in preexisting renal insufficiency: A case report

BACKGROUND: Ribociclib, one of the cyclin‐dependent kinases (CDK) 4 and 6 inhibitors, in combination with endocrine therapies has been approved in the treatment of hormonal receptor positive, HER‐2 negative metastatic breast cancer worldwide. Long‐term usage of ribociclib with concomitant drugs, pot...

Descripción completa

Detalles Bibliográficos
Autores principales: Lagampan, Chalita, Poovorawan, Nattaya, Parinyanitikul, Napa
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2021
Materias:
Case Reports
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9351659/
https://www.ncbi.nlm.nih.gov/pubmed/34739192
http://dx.doi.org/10.1002/cnr2.1575

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9351659/
https://www.ncbi.nlm.nih.gov/pubmed/34739192
http://dx.doi.org/10.1002/cnr2.1575

Ejemplares similares